A note from the editor
In 2013 Copenhagen hosted the Orphan Drugs Summit for the third time and offered over 150 delegates the unique opportunity to meet and interact with all major orphan drugs stakeholders.
Once again Orphan Drugs Summit proved it is the leading rare disease event in Northern Europe. A well-established platform where pharmaceutical companies of all sizes, hospital representatives, researchers, patient organizations, venture capitalists, regulatory bodies, and industry associations meet to discuss and influence the future of orphan drugs.
The Summit is designed to increase interaction among participants, promote knowledge flow and instigate partnerships and alliances for those working with orphan drugs.
Once again we have further increased networking opportunities and invited leading industry professionals with gripping presentations to address the following topics:
- Market Access challenges and strategies
- Incentives & regulatory framework
- Patient registries
- Access to Orphan Drugs
- Partnerships and Financing
- Pricing & Reimbursement
- Scientific & Clinical Development